Most Read Articles
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
Rachel Soon, 24 Apr 2019

With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.

Roshini Claire Anthony, 25 Jun 2020

Patients with rheumatoid arthritis (RA) treated with tumour necrosis factor (TNF) inhibitors may have a reduced risk of venous thromboembolism (VTE) compared with those treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), according to an observational study presented at EULAR 2020.

Multimodal approach reduces missed opportunities for influenza vaccination in RA patients

30 Sep 2018

Multimodal approach reduces missed opportunities for influenza vaccination in RA patients

Using a multimodal intervention may improve uptake of influenza vaccination in patients with rheumatoid arthritis (RA), reports a study, adding that some subgroups may need a more potent approach for equivalent efficacy.

Of the 228 patients with RA who participated in the study (904 preintervention visits), 197 returned for at least one postintervention visit (721 postintervention visits). There was a 47-percent preintervention frequency of any missed opportunities for influenza vaccination, and this decreased to 23 percent postintervention (p<0.001).

The relative hazard among those vaccinated for influenza vaccination post vs preintervention period was 1.24 (p=0.038).

Each of the following was independently associated with missed opportunities preintervention: younger age, less frequent office visits, higher erythrocyte sedimentation rate and negative attitudes about vaccines. These factors no longer correlated with missed opportunities postintervention.

However, the intervention appeared to be not as effective in the following: non-Hispanic black patients, non-English speakers, those residing outside of the New York City metropolitan area and those reporting prior adverse reactions to vaccines.

This study recruited RA patients from a single centre. The authors tracked each rheumatology outpatient visit for missed opportunities for influenza vaccination, defined as a visit in which an unvaccinated patient without contraindications remained unvaccinated or lacked documentation of vaccine recommendation in the electronic medical record (EMR).

Subsequently, providers received a multimodal intervention consisting of an education session, EMR alerts and weekly provider-specific e-mail reminders. The authors compared missed opportunities pre- and postintervention, and analysed the determinants of missed opportunities.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
Rachel Soon, 24 Apr 2019

With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.

Roshini Claire Anthony, 25 Jun 2020

Patients with rheumatoid arthritis (RA) treated with tumour necrosis factor (TNF) inhibitors may have a reduced risk of venous thromboembolism (VTE) compared with those treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), according to an observational study presented at EULAR 2020.